Kolon Life Science Inc. (KOSDAQ:102940)
South Korea flag South Korea · Delayed Price · Currency is KRW
49,600
+400 (0.81%)
Jun 12, 2026, 3:30 PM KST

Kolon Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9,60910,63612,4987,5616,37127,800
Short-Term Investments
-----110
Cash & Short-Term Investments
9,60910,63612,4987,5616,37127,910
Cash Growth
29.61%-14.90%65.29%18.68%-77.17%85.69%
Accounts Receivable
34,64337,20536,69924,60529,44019,649
Other Receivables
38.93216.611,0941,008302.04638.16
Receivables
34,68237,42137,79425,61329,74220,287
Inventory
65,29656,23646,72667,77768,49445,998
Prepaid Expenses
4,5603,3354,1273,4064,5793,743
Other Current Assets
781.78406.65909.02688.31998.1682.57
Total Current Assets
114,929108,035102,055105,045110,18498,021
Property, Plant & Equipment
133,247132,183115,076123,138125,960131,481
Long-Term Investments
894,658668,317197,22377,05475,2402,549
Goodwill
----1,2171,217
Other Intangible Assets
963.631,027554.34168.2858.9599.11
Long-Term Accounts Receivable
-00-00-0-0
Long-Term Deferred Charges
-1.544.86164.25283.64403.04
Other Long-Term Assets
4,6714,8504,6103,8661,174888.54
Total Assets
1,148,469914,413419,563309,436314,118234,658
Accounts Payable
13,71412,93011,9507,44217,04913,774
Accrued Expenses
3,5645,0574,9084,3553,5943,145
Short-Term Debt
99,37392,155105,89097,26269,46159,064
Current Portion of Long-Term Debt
9,9904,9969,993-4,0005,333
Current Portion of Leases
861.3628.43692.76428.66287.62336.45
Current Income Taxes Payable
138.23599.13--376.36-
Current Unearned Revenue
3,2013,2013,2013,2013,2013,500
Other Current Liabilities
27,35850,21669,62015,65311,60810,316
Total Current Liabilities
158,199169,783206,255128,341109,57895,469
Long-Term Debt
-4,9908,6999,980-4,000
Long-Term Leases
1,160960.431,324191.33167.18191.02
Pension & Post-Retirement Benefits
-3,4986,8316,4399,81210,449
Long-Term Deferred Tax Liabilities
188,717138,95433,6299,8749,760-
Other Long-Term Liabilities
16,26212,19613,48716,93817,07825,139
Total Liabilities
364,338330,382270,225171,764146,395135,248
Common Stock
6,5456,4546,2125,7065,7065,706
Additional Paid-In Capital
211,010208,233192,801167,553209,114209,542
Retained Earnings
-182,695-203,380-228,091-133,289-101,537-106,024
Treasury Stock
------812.88
Comprehensive Income & Other
749,270572,724178,41797,70254,440-9,001
Shareholders' Equity
784,131584,030149,338137,672167,72399,410
Total Liabilities & Equity
1,148,469914,413419,563309,436314,118234,658
Total Debt
111,384103,730126,598107,86373,91668,925
Net Cash (Debt)
-101,776-93,094-114,100-100,301-67,545-41,015
Net Cash Per Share
-6964.64-6496.63-9553.48-8788.83-5344.94-3597.74
Filing Date Shares Outstanding
13.0312.9112.4211.4111.4111.4
Total Common Shares Outstanding
13.0312.9112.4211.4111.4111.4
Working Capital
-43,270-61,748-104,200-23,296606.752,552
Book Value Per Share
60178.5545248.7112020.6812063.4114696.648720.06
Tangible Book Value
783,167583,003148,783137,504166,44898,094
Tangible Book Value Per Share
60104.5945169.1411976.0512048.6714584.868604.64
Land
16,31616,31616,28116,28117,28617,008
Buildings
63,35386,46881,46288,06988,56788,891
Machinery
34,584123,620108,063104,638101,589102,952
Construction In Progress
16,95918,05613,85717,81016,47415,952